1. Home
  2. Labeler Index
  3. Accord Healthcare Inc.
  4. 16729-240
  5. NDC Package Code: 16729-240-03 Fosaprepitant

NDC Package 16729-240-03 Fosaprepitant

Injection, Powder, Lyophilized, For Solution Intravenous - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
16729-240-03
Package Description:
1 VIAL, SINGLE-DOSE in 1 CARTON / 5 mL in 1 VIAL, SINGLE-DOSE
Product Code:
16729-240
Proprietary Name:
Fosaprepitant
Non-Proprietary Name:
Fosaprepitant
Substance Name:
Fosaprepitant Dimeglumine
Usage Information:
Fosaprepitant is used with other medications to help prevent nausea and vomiting caused by cancer drug treatment (chemotherapy). Fosaprepitant works by blocking one of the body's natural substances (substance P/neurokinin 1) that causes vomiting. This medication will not treat nausea or vomiting that has already started. Ask your doctor what you should do if you already have nausea or vomiting.
11-Digit NDC Billing Format:
16729024003
NDC to RxNorm Crosswalk:
  • RxCUI: 1731077 - fosaprepitant 150 MG Injection
  • RxCUI: 1731077 - fosaprepitant 150 MG (as fosaprepitant dimeglumine 245.3 MG) Injection
    • Product Type:
    Human Prescription Drug
    Labeler Name:
    Accord Healthcare Inc.
    Dosage Form:
    Injection, Powder, Lyophilized, For Solution - A dosage form intended for the solution prepared by lyophilization ("freeze drying"), a process which involves the removal of water from products in the frozen state at extremely low pressures; this is intended for subsequent addition of liquid to create a solution that conforms in all respects to the requirements for Injections.
    Administration Route(s):
  • Intravenous - Administration within or into a vein or veins.
    • Active Ingredient(s):
  • FOSAPREPITANT DIMEGLUMINE 150 mg/5mL
    • Pharmacologic Class(es):
  • Cytochrome P450 2C9 Inducers - [MoA] (Mechanism of Action)
  • Cytochrome P450 3A4 Inducers - [MoA] (Mechanism of Action)
  • Cytochrome P450 3A4 Inhibitors - [MoA] (Mechanism of Action)
  • Neurokinin 1 Antagonists - [MoA] (Mechanism of Action)
  • Substance P/Neurokinin-1 Receptor Antagonist - [EPC] (Established Pharmacologic Class)
    • Sample Package:
    No
    FDA Application Number:
    ANDA204025
    Marketing Category:
    ANDA - A product marketed under an approved Abbreviated New Drug Application.
    Start Marketing Date:
    10-22-2020
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 16729-240-03?

    The NDC Packaged Code 16729-240-03 is assigned to a package of 1 vial, single-dose in 1 carton / 5 ml in 1 vial, single-dose of Fosaprepitant, a human prescription drug labeled by Accord Healthcare Inc.. The product's dosage form is injection, powder, lyophilized, for solution and is administered via intravenous form.

    Is NDC 16729-240 included in the NDC Directory?

    Yes, Fosaprepitant with product code 16729-240 is active and included in the NDC Directory. The product was first marketed by Accord Healthcare Inc. on October 22, 2020 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the 11-digit format for NDC 16729-240-03?

    The 11-digit format is 16729024003. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-3-216729-240-035-4-216729-0240-03